NRC Health
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Trent Green
- Full Time Employees
- 357
- Sector
- Health services
- Industry
- Services to the health industry
- Address
- 1245 Q Street Lincoln NE United States 68508
- IPO Date
- Oct 10, 1997
- CIK
- 0000070487
- Website
- nrchealth.com
- Similar Companies
- Business
- National Research Corporation (NRC) operates as a healthcare insights and analytics company specializing in healthcare experience management solutions designed to enhance patient, employee, physician, and consumer engagement. Its core offerings include multi-channel feedback collection and analysis platforms; patient and family experience measurement; resident and family experience programs for long-term care; employee and physician engagement solutions; healthcare analytics encompassing market and clinical outcomes analysis; health risk assessments; patient outreach initiatives; and integrated healthcare experience management solutions. NRC delivers these services primarily to healthcare providers, hospitals, and long-term care facilities across the United States with a strong emphasis on human-centered conversational listening enhanced by next-generation artificial intelligence technologies. Founded in 1981 and headquartered in Lincoln, Nebraska, NRC has recently focused on transformative growth by integrating advanced AI capabilities into its product suite to deliver more adaptive and personalized healthcare experience management tools. In 2024–2025, the company intensified investments in AI-enhanced healthcare-specific solutions set for market rollout, expanded its sales force, and pursued strategic initiatives to deepen customer engagement and market penetration. NRC also returned $18 million to shareholders through dividends and stock repurchases during the first quarter of 2024, signaling robust financial stewardship. The company's strategic roadmap includes leveraging AI and broadening its healthcare experience platform to better serve evolving client needs in a competitive market. NRC continues to reinforce its position as a leader in healthcare experience analytics by advancing innovative solutions that address regulatory compliance, patient satisfaction, and operational performance improvements. NRC operates exclusively in the healthcare industry with offerings tailored to hospitals, healthcare systems, long-term care providers, and related healthcare organizations across North America. The company maintains a comprehensive portfolio of market insights, consumer assessment programs (including CMS-approved surveys), clinical analytics, and consulting services. Its recent operational enhancements and AI focus position NRC at the forefront of delivering actionable data-driven insights that help healthcare organizations optimize patient outcomes, satisfaction, and loyalty while navigating regulatory and market pressures effectively.
Company News
Terra Innovatum Achieves Key NRC Licensing Milestone, Delivers All 18 SOLO™ PSAR Chapters for Readiness Review as it Advances Toward 2027 First Reactor Deployment
NRC Completes Landmark Safety Review of X-energy's Xe-100 SMR
RETRANSMISSION: Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project
Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project
National Research Q3 Earnings Call Highlights
NRC Health Announces Third Quarter 2026 Results
NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams
NuScale Power Trades Below $6 With the Only NRC-Certified Small Modular Reactor Design. Here's Why That Still Isn't Enough.
Terra Innovatum Advances SOLO™ Construction Permit Application and Reactor Procurement, Reaffirms Fully Funded Path to 2027 First-Of-A-Kind Deployment
Head-To-Head Comparison: Phreesia (NYSE:PHR) & National Research (NASDAQ:NRC)
New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action
National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?
NANO Nuclear's KRONOS MMR™ Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign
NANO Nuclear's KRONOS MMR(TM) Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign
Head to Head Survey: National Research (NASDAQ:NRC) vs. Teladoc Health (NYSE:TDOC)
NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets
Former U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo's Board of Directors in January 2027
NRC Health Trades at a Discount: Should You Buy, Sell or Hold?
New Momentum in the Nuclear Fuel Chain
KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score